INTRODUCTION
Streptococcus suis is a major worldwide swine pathogen that can also cause occupation-related infections in humans who work in close contact with pigs or pork by-products (Fittipaldi et al., 2012; Gottschalk et al., 2010) . It has been associated with severe infections in pigs such as meningitis, arthritis, pneumonia and septicaemia (Fittipaldi et al., 2012; Gottschalk et al., 2010) . Although there are 35 known serotypes, serotype 2 is the most prevalent isolated from diseased pigs in many countries (Staats et al., 1997) .
The alternative pathway of the complement system is initiated spontaneously and generates C3b molecules which bind directly to any surface (Nilsson & Ekdahl, 1998) .
Many regulatory proteins, including factor H, are produced to protect host cells from C3b components of the complement system (Zipfel & Skerka, 2009 ). More specifically, factor H has been shown to be a 150 kDa single-chain glycoprotein composed of 20 repetitive protein domains called short consensus repeats (Rodríguez de Có rdoba et al., 2004) . It acts as a cofactor for the cleavage of surface-bound C3b by factor I to generate inactive iC3b (Rodríguez de Có rdoba et al., 2004) . It also competes with factor B for binding to C3b, therefore interfering with the formation of the C3bBb complex (Rodríguez de Có rdoba et al., 2004) . Upon entry into a host, any micro-organism is attacked by the complement system. However, many important pathogenic streptococci have evolved the ability to bind factor H to their cell surface to avoid complement attack and phagocytosis (Jarva et al., 2003; Oliver et al., 2008 an immunoproteomic approach, Geng et al. (2008) identified a series of cell wall and extracellular proteins in S. suis with high immunogenicity suggesting their strong potential to be vaccine candidates. BLASTP analysis revealed that one of them, corresponding to SSU98_0197 in S. suis 98HAH33, shared similarity with a Streptococcus pneumoniae protein (named PspC) possessing a factor H-binding activity (Geng et al., 2008) . The aim of this study was to clone, purify and characterize this putative factor H-binding protein expressed on the cell surface of S. suis serotype 2.
METHODS
Plasmids, bacterial strains and growth conditions. The strains and plasmids used in this study are listed in Table 1 . S. suis strains were grown under static conditions at 37 uC in Todd-Hewitt broth (BBL Microbiology Systems). Escherichia coli strains were grown with aeration at 37 uC in Luria-Bertani broth (BBL Microbiology Systems). When necessary, kanamycin (30 mg ml 21 ) was added.
Proteins and antibodies. Factor H (human), factor I (human), goat anti-human factor H antibody and goat anti-human C3b antibody were purchased from the Quidel Corporation, while C3b protein was obtained from Calbiochem EMD Chemicals. Alkaline phosphatase (AP)-conjugated mouse anti-goat IgG antibody, AP-conjugated goat anti-pig IgG antibody and horseradish peroxidase (HRP)-conjugated mouse anti-goat IgG antibody were purchased from Santa Cruz Biotechnology.
Assay for human factor H-binding activity of S. suis. Cell-based ELISA was used to demonstrate the binding of factor H to the cell surface of three strains of S. suis (S735, P1/7, 31533). Bacterial cells were harvested by centrifugation and suspended at OD 660 0.25 in 50 mM carbonate buffer (pH 9.6). The bacterial suspension (100 ml per well) was added to the wells of a flat-bottomed 96-well microplate (Nunc-Immuno MaxiSorp; Nalge Nunc International), which was incubated for 2 h at room temperature. Thereafter, the bacterial suspension was removed by aspiration and the attached bacteria were fixed with 0.05 % glutaraldehyde for 45 min. The wells were washed three times with 50 mM PBS (pH 7.2) containing 0.5 % BSA and 0.05 % Tween 20 (PBS-BSAT). PBS (100 ml) containing 1 mg of human factor H or 10 % human serum was then added to the wells, and the plate was incubated for 2 h at room temperature with gentle shaking. Wells were further washed three times with PBS-BSAT to remove unbound factor H. Factor H bound to bacteria was determined using goat anti-human factor H antibody (1 : 30 000) and then HRP-conjugated mouse anti-goat IgG antibody (1 : 30 000). After adding the HRP substrate to allow colour development, the absorbance at 450 nm (A 450 ) was recorded with a microplate reader. Background values obtained in the absence of factor H or serum treatment of bacterial cells were subtracted. All assays were performed in triplicate and the means±SD were calculated.
C3b cleavage assay. The functional activity of factor H bound to S. suis was assayed using a factor I-cofactor assay. Briefly, S. suis cells were incubated with human factor H (0.7 mg ml 21 ) for 2 h at 37 uC. Bacteria were then washed three times in PBS and suspended in the same buffer, and human C3b (4.5 mg ml 21 ) and human factor I (2.5 mg ml 21 ) were added. The positive control for C3b cleavage contained factor H, factor I and C3b. Following incubation at 37 uC for 2 h, denaturing electrophoresis buffer was added and the mixture was subjected to SDS-10 % PAGE . Proteins were electrophoretically transferred onto a nitrocellulose membrane and C3b degradation products were visualized by Western immunoblotting using goat antihuman C3b (1 : 500) and then AP-conjugated mouse anti-goat IgG antibody (1 : 1000). Bands were revealed by adding the AP substrate.
DNA purification and manipulation. Chromosomal DNA was isolated from S. suis P1/7 as previously described (Bonifait et al., 2011) . Unless otherwise mentioned, DNA manipulations were performed in accordance with standard procedures (Ausubel et al., 1997) . Transformation in E. coli Top10 was carried out using One Shot Top10-competent cells (Invitrogen) as described by the supplier. (Sambrook et al., 1989) . DNA fragments used for sequencing and subcloning were purified with a Qiagen purification kit (Qiagen).
Distribution of SSU0186 in S. suis strains. In addition to S. suis P1/7, additional strains of S. suis serotype 2 (31533, S735, 65, 94-623, T15) or belonging to serotype 1 (S428), 1/2 (2651), 3 (4961) or 5 (Amy12C) were tested for the presence of the SSU0186 gene. Cell lysates were prepared from bacterial colonies recovered from agar plates. The presence of the gene was determined by PCR using the forward primer H8X (59-TATCTCGAGGGAAACTGCAAATAAA-AAATT-39) and the reverse primer H1100R (59-GGTTGCTCC-ATTTCTGGTTGCTTAG-39). The PCR was performed with a DNA Thermal Cycler 480 (PerkinElmer) according to the EconoTaq reaction protocol (Lucigen). The reaction was carried out for 30 cycles with the following temperature-time profile: 94 uC for 1 min, 45 uC for 1 min, and 72 uC for 2 min. At the end of the amplification process, the samples were incubated at 72 uC for 3 min. Products were analysed on a 0.8 % agarose gel (110 V for 45 min).
Gene cloning. S. suis P1/7 SSU0186, the gene corresponding to SSU98_0197 (uncharacterized protein) in S. suis 98HAH33 and which was reported to share similarity with the S. pneumoniae PspC protein possessing a factor H-binding activity (Geng et al., 2008) , was PCR amplified by using the forward primer H-8 N (59-TATACA-TATGGAAACTGCAAATAAAAAATT-39), which contained an engineered NdeI site (underlined), and the reverse primer H1769R-X (59-AATCTCGAGGATTTGATCTTTAGATTTTT-39), which contained an engineered XhoI site (underlined). Primer H-8 N covered positions 7 to 23 relative to the adenine of the ATG initiation codon of S. suis P1/7 SSU0186, while primer H1769R-X covered positions 1664 to 1692. The PCR was carried out as above. An amplified DNA fragment of 1699 bp was obtained. After digestion with NdeI and XhoI, the amplicon was cloned into expression plasmid pET29b to yield the plasmid pHpL8, which was propagated in E. coli Top10. The nucleotide sequence of the DNA fragment cloned into pHpL8 was confirmed by sequencing both DNA strands by the dideoxy chaintermination method of Sanger et al. (1977) . DNA sequencing was carried out by the DNA sequencing service at Université Laval with an ABI Prism 3130XL apparatus. The plasmid pHpL8 was then used to transform strain E. coli BL21DE3.
Protein overproduction and purification. Transformed E. coli BL21DE3 [pHpL8] cultures were induced at mid-exponential phase (OD 600 0.4-0.7) after growth at 37 uC in Luria-Bertani medium supplemented with kanamycin (30 mg ml 21 ). Inductions were carried out with 1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) for 4 h. Cells were then harvested by centrifugation and a cellular extract was prepared by sonication. The recombinant SSU0186 protein was purified using a Ni-Sepharose High Performance column (GE Healthcare) and a MonoQ 5/50 GL column (GE Healthcare) connected to an FPLC LKB Controller LCC-500 Plus (GE Healthcare). The collected fractions were analysed by SDS-10 % PAGE and Coomassie blue staining. Fractions containing the pure protein were pooled and stored at 280 uC in the presence of 10 % (v/v) glycerol.
Computer analysis of sequence data. Computer-assisted DNA and protein sequence data analyses were performed with the BioEdit software. To determine the different domains in the SSU0186 protein, software available at http://www.ch.embnet.org/software/COILS_ form.html, http://www.vivo.colostate.edu/molkit/hydropathy/ and http://www.cbs.dtu.dk/services/SignalP/ were used.
Assay for human factor H-binding activity of recombinant SSU0186 protein. The binding of human factor H to recombinant SSU0186 protein was first evaluated by a solid-phase dot blot enzyme procedure using goat anti-human factor H antibody (1 : 200) and then HRP-conjugated mouse anti-goat IgG (1 : 5000). Factor H (10 mg ml 21 ) binding to recombinant SSU0186 protein (90 to 5.6 mg ml -1 ) was visualized using an enhanced chemiluminescence Western blot kit (PerkinElmer) according to the manufacturer's instructions. The factor H-binding capacity of recombinant SSU0186 protein was confirmed by ELISA as described above. Microplate wells were coated with a dilution series of the recombinant protein (10, 1 and 0.1 mg ml
21
).
Immunoreactivity of the recombinant SSU0186 protein with pig sera. Sera from convalescent 4-week-old piglets that were infected intravenously with 10 7 c.f.u. of an exponential-phase culture of S. suis strains S735, 1591 or 31533, all belonging to serotype 2, were prepared according to the protocol of Esgleas et al. (2009) . Animals originated from a farm considered free of S. suis serotype 2 infections. Sera from non-infected animals were used as negative controls. All animal experiments were conducted according to the guidelines and protocols set by the Canadian Council on Animal Care and approved by the Université de Montréal committee on animal care. The recombinant SSU0186 protein was migrated on a 10 % polyacrylamide gel under denaturing conditions and electrophoretically transferred to a nitrocellulose membrane in the presence of 10 mM N-cyclohexyl-3-aminopropanesulfonic acid buffer, pH 11, and 10 % methanol. Five-millimetre-wide nitrocellulose strips were prepared and used for the immunoblot analysis. They were incubated for 1 h at room temperature in TBS containing 5 % fat-free milk. The membranes were washed twice with TTBS and then immersed in pig sera (diluted 1 : 500 in TTBS containing 2 % fat-free milk). After 2 h, with slight agitation, the strips were washed and then incubated for 1 h at room temperature with AP-goat anti-pig-IgG (diluted 1 : 30 000). The strips were washed and colour development was performed as above. The appearance of a reactive band is indicative of the presence of anti-SSU0186 antibodies in sera.
RESULTS
Binding of human complement factor H to the surface of three S. suis serotype 2 strains (S735, P1/7, 31533) was demonstrated using cell-based ELISA. Results presented in Table 2 indicate that all three strains of S. suis bound factor H to various extents, the highest reactivity being observed with the strain S735. S. suis was also found to acquire factor H on its surface following incubation in the presence of human serum (Table 2) . Heat treatment (60 u C for 30 min) of S. suis cells resulted in a decreased ability to bind factor H, suggesting heat sensitivity of the receptor ( Table 2 ). The functional activity of factor H bound to the surface of S. suis was tested using a factor I-cofactor assay. Both C3b and factor I components were added to cells pre-treated with factor H and after incubation C3b degradation products were identified by SDS-PAGE/Western immunoblotting. Fig. 1 revealed the cofactor activity of factor H bound to S. suis P1/7 by the appearance of the a' 68 kDa cleavage product. The same band was generated in the positive control assay, which consists in the incubation of soluble factor H with factor I and C3b. A similar functional activity of bound factor H was also found for strains S735 and 31533 (data not shown).
The 1686 bp open reading frame corresponding to SSU0186 (uncharacterized protein) in the genomic sequence of S. suis P1/7 was used to design oligonucleotide primers for PCR amplification of the putative factor Hbinding protein. Selection of this gene was based on a previous study by Geng et al. (2008) who showed by BLASTP analysis that SSU98_0197 in S. suis 98HAH33 (corresponds to SSU0186 in strain P1/7) shared similarity with an S. pneumoniae protein (named PspC) possessing factor Hbinding activity. The open reading frame of SSU0186 encoded a 561 amino acid protein and had a G+C content of 44.5 %, which is slightly higher than that of the S. suis genome (38-42 %) (Okwumabua et al., 2001 ). There were a tagatose-6-phosphate aldose/ketose isomerase upstream and an Xaa-Pro dipeptidyl-peptidase downstream of SSU0186 (data not shown). The SSU0186 protein contained the Gram-positive cell wall anchoring motif (LeuPro-Ala-Thr-Gly) at the carboxy terminus at positions 524 to 528 followed by a hydrophobic domain (Fig. 2) . It also contained an amino-terminal signal sequence with a putative cleavage site between residues 40 (alanine) and 41 (threonine), an a-helix domain, a proline-rich region and a G5 domain (named after its conserved glycine residues) (Fig. 2) .
To explore the distribution of genes homologous to SSU0186 in S. suis serotype 2, the published genome sequences of 12 strains of S. suis belonging to serotypes 1, 1/2, 2, 3 and 5 were subjected to bioinformatic analysis. As reported in Table 3 , the predicted amino acid sequence analysis revealed the existence of two groups of factor Hbinding proteins homologous to SSU0186: a first group including seven strains (five belonging to serotype 2) with a high degree of homology (89 to 100 %) with SSU0186 of S. suis P1/7, and a second group of five strains (only one belonging to serotype 2) with a lower level of homology (42 to 52 %). Fig. 2 shows the schematic representation of SSU0186 of S. suis P1/7 and homologous proteins from three strains of S. suis showing a low degree of homology. In these latter strains, only the C-terminal region (±200 amino acids) which includes the G5 domain and the anchoring motif was highly conserved. The high variability observed in the a-helix domain and the proline-rich region may explain their low homology with SSU0186. Furthermore, the protein of strain ST1 (serotype 1) contains three additional G5 domains.
To confirm results of the bioinformatic analysis performed indicating the presence of homologous SSU0186 in various strains of S. suis belonging to different serotypes, a PCR experiment was performed. As shown in Fig. 3 , all strains tested showed the presence of the gene encoding the factor H-binding protein.
The SSU0186 protein of S. suis showed various degrees of homology with previously reported factor H-binding proteins; the highest being with those produced by S. pneumoniae (data not shown). The structural organization of SSU0186 was then compared with the factor H-binding proteins produced by S. pneumoniae (Hic, CbpA), S. agalactiae (Bac) and S. pyogenes (ScI1) (Fig. 4a) . As found in SSU0186, all proteins contained a signal peptide, an ahelix domain and a proline-rich region. However, a high degree of variability was found in the carboxy-terminal region of the proteins. None of the streptococcal factor Hbinding proteins contained the G5 domain identified in SSU0186, whereas a collagen-like domain was present only in Scl1 of S. pyogenes. As for SSU0186, the proteins Hic, Bac and ScI1 were anchored to the bacterial cell wall through an LPXTG motif. The factor H-binding protein CbpA of S. pneumoniae was surface attached through a series of repeats with choline-binding motifs. The 12-amino acid sequence of the factor H-binding domain previously identified in CbpA (S. pneumoniae) (Lu et al., 2006) was aligned in proteins PspC (S. pneumoniae), Hic (S. pneumoniae) and SSU0186 (S. suis). As shown in Fig.  4b , SSU0186 had four amino acids in common with CbpA, while PspC and Hic had respectively five and seven amino acids in common with CbpA. Fig. 1 . Demonstration of the capacity of factor H bound to S. suis P1/7 to serve as a cofactor for the factor I-mediated cleavage of C3b. Lane 1, molecular mass markers; 2, control S. suis cells; 3, factor H + factor I + C3b; 4, factor H-coated S. suis + factor I + C3b; 5, S. suis + factor I + C3b; 6, factor H-coated S. suis + C3b; 7, factor H-coated S. suis + factor I. Molecular mass markers are, from top to bottom: myosin (200 kDa), b-galactosidase (116 kDa) and BSA (80 kDa). The PCR amplified DNA fragment encoding the putative factor H-binding protein SSU0186 of S. suis was cloned into the expression vector pET29b to generate the 6.9 kb plasmid pHpL8. After induction of expression in E. coli containing pHpL8, the His-tagged recombinant protein was purified using nickel affinity and ion-exchange chromatography procedures. The purification procedure gave 360 mg of pure SSU0186 from 1 l of culture. As shown in Fig. 5 , the recombinant protein was highly pure and showed a molecular mass of 95 kDa. The recombinant SSU0186 protein was first tested in a solid-phase dot blot enzyme procedure for its functional ability to bind factor H. Fig. 6 shows that purified SSU0186 possessed a dosedependent factor H-binding activity. The interaction between recombinant SSU0186 protein and factor H was also tested by ELISA. As reported in Table 4 , the factor Hbinding activity of the recombinant protein was concentration-dependent.
Lastly, to investigate whether the factor H-binding protein of S. suis is an important antigen during infection, we tested its reactivity with sera from S. suis-infected pigs. As shown in Fig. 7 , all three sera from diseased pigs reacted with the 95 kDa protein while serum from a healthy pig did not react.
DISCUSSION
The complement system is the first line of defence against pathogenic micro-organisms and therefore an important part of the immune system. In most cases, microorganisms activate the complement cascade, which eventually leads to phagocytosis and/or formation of the membrane attack complexes (Nilsson & Ekdahl, 1998) . Factor H is a fluid-phase protein that regulates the alternative pathway of the complement system by acting as a cofactor for factor I in the degradation of C3b. It ensures that the complement system is directed towards pathogens and does not damage host tissues (Nilsson & Ekdahl, 1998; Zipfel & Skerka, 2009) . During the initial phase of S. suis infection, when bacteria reach the bloodstream, complement evasion is likely critical. In this study, we showed that S. suis has the ability to bind factor H on its cell surface. The biological relevance of factor Hbinding activity of S. suis was investigated by assaying C3b cleavage. The demonstration that surface-bound factor H can contribute to C3b cleavage suggests a mechanism by which S. suis can resist complement-mediated killing. It may be suggested that, in addition to the capsule, which Comparative bioinformatic analysis of the S. suis P1/7 SSU0186 putative factor H-binding protein with homologous proteins in other strains of S. suis. W, Cell wall anchor with LPXTG motif; G5D, G5 domain (named after its conserved glycine residues); PRR, proline-rich region; SP, signal peptide. Fig. 3 . Detection of the SSU0186 gene in S. suis strains. Lane 1, DNA molecular mass markers; 2, P1/7; 3, 31533; 4, S735; 5, 65; 6, 94-623; 7, T15; 8, S428; 9, 2651; 10, 4961; 11, Amy12C.
prevents the deposition of complement, the factor H-binding protein of S. suis may contribute to the cleavage of any deposited complement, thus contributing to evasion of the complement system. Very recently, Pian et al. (2012) identified a 77 kDa (calculated molecular mass) surface protein (SSU05_0272) that contributes to the virulence of S. suis serotype 2 (strain 05ZYH33) in a piglet infection model. This LPXTG-anchored protein was found to possess the capacity to bind complement factor H (Pian et al., 2012) . In addition to the difference in their molecular mass, analysis of the amino acid sequences of SSU05_0272 (called Ssfhb) and SSU0186 showed a very low percentage homology, suggesting two different genes. As a matter of fact, both SSU0186 and SSU05_0272 (named SSU0253 in strain P1/7) genes were found to be present in strain P1/7 . SDS-PAGE analysis of the recombinant SSU0186 putative factor H receptor of S. suis. Lane 1, molecular mass markers; 2, E. coli cell lysate from induced culture; 3, partially purified fraction following ion-exchange chromatography; 4, purified recombinant SSU0186 protein. . Binding of factor H by recombinant SSU0186 putative factor H receptor of S. suis P1/7, as determined by a dot blotting immunoassay. Row 1, serial dilutions (1 : 2) of recombinant SSU0186 (from 90 to 5.6 mg ml "1 ) applied on the PVDF membrane. Row 2, serial dilutions (1 : 2) of recombinant SSU0186 (from 90 to 5.6 mg ml "1 ) applied on the PVDF membrane and then reacted with human factor H. Row 3, serial dilutions (1 : 2) of human factor H (from 100 to 6.25 mg ml "1 ). The membrane was reacted with goat anti-human factor H antibody and then with HRP-conjugated mouse anti-goat IgG.
(data not shown), suggesting that factor H-binding activity of S. suis involves at least two cell surface receptors. Lastly, Shao et al. (2011) identified an immunogenic cell surfaceassociated protein of 110 kDa, called HtpS (histidine triad protein of S. suis). This protein, expressed during S. suis infections, appears to be involved in evasion of complement-mediated host innate immune responses by preventing C3 deposition on the surface of S. suis (Shao et al., 2011) . The exact mechanism by which HtpS decreases C3 deposition has not been described.
The putative gene coding for the factor H-binding protein of S. suis P1/7 was identified based on a previous study by Geng et al. (2008) , who used an immunoproteomic approach to show that a protein (SSU98_0197) having homology with a factor H-binding protein of S. pneumoniae had a high immunogenicity, supporting its potential to be a vaccine candidate. We found that the SSU0186 factor H-binding protein of S. suis P1/7 contained an ahelix domain, a proline-rich region and a G5 domain. The a-helix domain, located at the N terminus of SSU0186 (residues 41 to 200), is highly charged and the secondary structure is predominantly a-helical. Computer-based structural analysis of SSU0186 using the COILS program identified three a-helices with the potential to form coiledcoil motifs. Coiled-coil motifs have a heptad repeat (abcdefg) n with residues a and d being hydrophobic and residues e and g generally being charged (McDowell et al., 2004) . The a-helical region is followed by a proline-rich domain (residues 201 to 408). The proline-rich region consists of irregular repeats marked by the presence of a proline residue every two or three amino acids; the alanine and lysine residues are also common. In the SSU0186 protein, the proline-rich region contained 26.9 % proline residues, 13.5 % alanine residues and 10.6 % lysine residues. The pentamer PAPAP appears twice in this region. The proline-rich domain of SSU0186 contains two repeat regions of 23 amino acids interrupted by 24 amino acids. Between the proline-rich region and the C-terminal region, a short sequence, named the G5 domain, with a secondary structure rich in b-sheet is found. The name G5 domain derives from the observed conservation of five glycines (Ruggiero et al., 2009) . In SSU0186, the G5 domain possesses 85 amino acids with six glycines of which five are highly conserved. This module is found in a variety of enzymes such as the streptococcal IgA peptidases and various glycosyl hydrolases in bacteria (Ruggiero et al., 2009) . The distribution of SSU0186 in S. suis was investigated from the published genome sequences of 12 strains of S. suis. This analysis showed heterogeneity, a first group of strains having a corresponding protein with high homology with SSU0186 and a second group with poor homology, more specifically in the N-terminal part of the protein. The heterogeneity appears not to be related to serotype. Such a variability in factor H-binding proteins expressed by a bacterial species has been previously reported for PspC of S. pneumoniae (Iannelli et al., 2002) . Indeed, 11 major families of PspC proteins have been identified by sequence comparison (Iannelli et al., 2002) .
The SSU0186 of S. suis was cloned in E. coli and the recombinant protein showed a functional capacity to bind factor H. Factor H-binding proteins expressed by pathogenic streptococci may also act as adhesins and be involved in host colonization. For instance, a mutant of S. pneumoniae deficient in the expression of the cell surface factor H-binding protein CbpA showed an attenuated ability to adhere to nasopharynx epithelium and to cause infection in animal models (Balachandran et al., 2002; Iannelli et al., 2004) . Studies are currently in progress in our laboratory to investigate the roles of the SSU0186 protein in adhesion of S. suis to host cells.
The detection in the sera of S. suis-infected pigs of antibodies directed against the recombinant SSU0186 suggested that the factor H-binding protein is expressed in vivo and is recognized by the porcine immune system. This provides additional support for a major pathogenic role for this cell surface receptor. Interestingly, Li et al. (2010) reported that the expression of gene SSU05_0196 in S. suis 05ZYH33 (corresponds to SSU0186 in strain P1/7) is upregulated in the porcine brain and lung during experimental infections.
Given the evidence suggesting that SSU0186 of S. suis is a major immunogenic factor, it may be a promising candidate for a protein-based vaccine. It may represent an interesting vaccine candidate since anti-factor Fig. 7 . Identification of the SSU0186 of S. suis by porcine sera, as determined by SDS-PAGE and Western immunoblotting. Lane 1, serum from a non-infected pig; 2, serum from a pig infected with S. suis B735; 3, serum from a pig infected with S. suis 1591; 4, serum from a pig infected with S. suis 31533.
H-binding protein antibodies may have a dual action by mediating bacteriolysis via the classical complement pathway and by preventing binding of factor H to bacteria thus increasing their susceptibility to complement attack. Interestingly, a factor H-binding protein is a component of the multivalent serogroup B Neisseria meningitidis vaccine that is currently in human clinical trials (Giuliani et al., 2006) . Considering the heterogeneity in factor H-binding activity of S. suis related to SSU0186, it may be necessary to design and prepare a recombinant protein possessing all relevant epitopes and domains.
In conclusion, this study identified a novel S. suis protein that binds complement factor H. This cell surface protein may represent a virulence factor for S. suis as well as a putative vaccine candidate.
